Frontiers | Signaling Crosstalk between Steroid Hormone Receptors and p53, Rb and other Tumor Suppressor Proteins in Breast Cancer

Signaling Crosstalk between Steroid Hormone Receptors and p53, Rb and other Tumor Suppressor Proteins in Breast Cancer

4,194
Total downloads
13k
Total views and downloads

Articles

SYSTEMATIC REVIEW

Published on 24 Aug 2022

CDK4/6 inhibitors versus PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: An updated systematic review and network meta-analysis of 28 randomized controlled trials

Hangcheng Xu
Yan Wang
Yiqun Han
Yun Wu
Jiayu Wang
Binghe Xu

CDK4/6 inhibitors versus PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: An updated systematic review and network meta-analysis of 28 randomized controlled trials

doi 10.3389/fonc.2022.956464

3,513 views
5 citations

REVIEW

Published on 18 Aug 2022

Comparative review of pharmacological therapies in individuals with HER2-positive advanced breast cancer with focus on hormone receptor subgroups

Chinyereugo M. Umemneku-Chikere
Olubukola Ayodele
Marta Soares
Sam Khan
Keith Abrams
Rhiannon Owen
Sylwia Bujkiewicz

Comparative review of pharmacological therapies in individuals with HER2-positive advanced breast cancer with focus on hormone receptor subgroups

doi 10.3389/fonc.2022.943154

2,816 views
3 citations

REVIEW

Published on 03 Nov 2021

MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer

Neil Portman
Julia Chen
Elgene Lim

MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer

doi 10.3389/fonc.2021.777867

3,016 views
6 citations

ORIGINAL RESEARCH

Published on 18 Jun 2021

LncRNA FGD5-AS1 Facilitates the Radioresistance of Breast Cancer Cells by Enhancing MACC1 Expression Through Competitively Sponging miR-497-5p

Ji Li
Changjiang Lei
Bineng Chen
Qingfang Zhu

LncRNA FGD5-AS1 Facilitates the Radioresistance of Breast Cancer Cells by Enhancing MACC1 Expression Through Competitively Sponging miR-497-5p

doi 10.3389/fonc.2021.671853

2,531 views
18 citations

Share on

Frontiers in Oncology

Frontiers in Oncology

Breast Cancer
Molecular and Cellular Oncology

Impact

13kTopic views
9,226Article views
4,194Article downloads